Burns
Volume 36, Issue 2 , Pages 239-251 , March 2010

Accelerated healing of skin burns by anti-Gal/α-gal liposomes interaction

,Accepted 6 April 2009.

References 

  1. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and anti-macrophage serum. Am J Pathol. 1975;78:71–100
  2. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock. 1995;4:233–240
  3. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–746
  4. Tyler MP, Watts AM, Perry ME, Roberts AH, McGrouther DA. Dermal cellular inflammation in burns. An insight into the function of dermal microvascular anatomy. Burns. 2001;27:433–438
  5. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005;15:599–607
  6. Franz MG, Steed DL, Robson MC. Optimizing healing of the acute wound by minimizing complications. Curr Probl Surg. 2007;44:691–763
  7. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, et al. Wound healing in MIP-1α(−/−) and MCP-1(−/−) mice. Am J Pathol. 2001;159:457–463
  8. Shallo H, Plackett TP, Heinrich SA, Kovacs EJ. Monocyte chemoattractant protein-1 (MCP-1) and macrophage infiltration into the skin after burn injury in aged mice. Burns. 2003;29:641–647
  9. Piccolo MT, Wang Y, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, et al. Chemotactic mediator requirements in lung injury following skin burns in rats. Exp Mol Pathol. 1999;66:220–226
  10. Heinrich SA, Messingham KA, Gregory MS, Colantoni A, Ferreira AM, Dipietro LA, et al. Elevated monocyte chemoattractant protein-1 levels following thermal injury precede monocyte recruitment to the wound site and are controlled, in part, by tumor necrosis factor-alpha. Wound Repair Regen. 2003;11:110–119
  11. Snyderman R, Pike MC. Chemoattractant receptors on phagocytic cells. Annu Rev Immunol. 1984;2:257–281
  12. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med. 1984;160:1519–1531
  13. Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffis JM. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988;56:1730–1737
  14. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3)-linked galactose residues. J Exp Med. 1985;162:573–582
  15. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci USA. 1987;84:1369–1373
  16. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem. 1988;263:17755–17762
  17. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 1993;14:480–482
  18. Good H, Cooper DKC, Malcolm AJK, Ippolito RM, Koren E, Neethling FA, et al. Identification of carbohydrate structures which bind human anti-porcine Abs: implications for discordant grafting in man. Transplant Proc. 1992;24:559–562
  19. Sandrin M, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes. Proc Natl Acad Sci USA. 1993;90:11391–11395
  20. Collins BH, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W, et al. Cardiac xenografts between primate species provide evidence for the importance of α-galactosyl determinant in hyperacute rejection. J Immunol. 1995;154:5500–5510
  21. Sachs DH, Sykes M, Robson SC, Cooper DK. Xenotransplantation. Adv Immunol. 2001;79:129–223
  22. Manches O, Plumas J, Lui L, Chaperot L, Molens JP, Sotto JJ, et al. Anti-Gal mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy with autologous tumor cells. Haematologica. 2005;90:625–634
  23. Damerau B. Biological activities of complement-derived peptides. Rev Physiol Biochem Pharmacol. 1987;108:151–206
  24. Solomkin JS. Neutrophil disorders in burn injury: complement, cytokines, and organ injury. J Trauma. 1990;30(12 Suppl.):S80–S85
  25. LaTemple DC, Abrams JT, Zhang SU, Galili U. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knock out mice for α1,3galactosyltranferase. Cancer Res. 1999;59:3417–3423
  26. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275–290
  27. Eto T, Iichikawa Y, Nishimura K, Ando S, Yamakawa T. Chemistry of lipids of the posthemolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes in rabbit. J Biochem (Tokyo). 1968;64:205–213
  28. Stellner K, Saito H, Hakomori S. Determination of aminosugar linkage in glycolipids by methylation. Aminosugar linkage of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch Biochem Biophys. 1973;133:464–472
  29. Dabrowski U, Hanfland P, Egge H, Kuhn S, Dabrowski J. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Determination of branching patterns of a ceramide pentadecasaccharide by 1H nuclear magnetic resonance. J Biol Chem. 1984;259:7648–7651
  30. Egge H, Kordowicz M, Peter-Katalinić J, Hanfland P. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids. J Biol Chem. 1985;260:4927–4935
  31. Hanfland P, Kordowicz M, Peter-Katalinic J, Egge H, Dabrowski J, Dabrowski U. Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosasaccharides from rabbit erythrocyte membranes by combined gas chromatography–mass spectrometry; electron-impact and fast-atom-bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear Overhauser effect 500-MHz 1H-n.m.r. spectroscopy. Carbohydr Res. 1988;178:1–21
  32. Honma K, Manabe H, Tomita M, Hamada A. Isolation and partial structural characterization of macroglycolipid from rabbit erythrocyte membranes. J Biochem (Tokyo). 1981;90:1187–1196
  33. Thall AD, Maly P, Lowe JB. Oocyte Gal α1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem. 1995;270:21437–21440
  34. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000;105:301–310
  35. Galili U. Immune response, accommodation and tolerance to transplantation carbohydrate antigens. Transplantation. 2004;78:1093–1098
  36. Galili U, Basbaum CB, Shohet SB, Buehler J, Macher BA. Identification of erythrocyte Galα1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem. 1987;262:4683–4688
  37. Galili U, Wigglesworth K, Abdel-Motal UM. Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines. J Immunol. 2007;178:4676–4687
  38. Oriol R, Candelier JJ, Taniguchi S, Balanzino L, Peters L, Niekrasz M, et al. Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research. Xenotransplantation. 1999;6:79–89
  39. Königová R, Matousková E, Broz L. Burn wound coverage and burn wound closure. Acta Chir Plast. 2000;42:64–68
  40. Chiu T, Pang P, Ying SY, Burd A. Porcine skin: friend or foe?. Burns. 2004;30:739–741
  41. Chiu T, Burd A. Xenograft dressing in the treatment of burns. Clin Dermatol. 2005;23:419–423

PII: S0305-4179(09)00111-9

doi: 10.1016/j.burns.2009.04.002

Burns
Volume 36, Issue 2 , Pages 239-251 , March 2010